Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
31,353,069
Share change
+1,142,574
Total reported value
$1,801,848,806
Put/Call ratio
69%
Price per share
$57.47
Number of holders
241
Value change
+$73,791,648
Number of buys
126
Number of sells
110

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2023

As of 30 Jun 2023 Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) had 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 31,353,069 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Neuberger Berman Group LLC, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and MORGAN STANLEY.
This table shows 241 institutional shareholders of the security as of 30 Jun 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.